Cite
HARVARD Citation
Bradley, J. et al. (n.d.). 1159. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Pediatric Participants With Confirmed or Suspected Gram-negative Bacterial Infections: A Phase 1b, Open-label, Single-Dose Clinical Trial. Open forum infectious diseases. p. S671. [Online].